Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1/2a Trial of Placental Mesenchymal Stem Cells for Repair of Fetal Myelomeningocele

NCT04652908 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT04652908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04652908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1/2a Trial of Placental Mesenchymal Stem Cells for Repair of Fetal Myelomeningocele
Lead sponsor
University of California, Davis
Phase
Phase 1/2
Overall status
Recruiting
Start date
June 21, 2021
Completion date
March 31, 2027
Enrollment
55 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myelomeningocele